Allergan Breast Implant Lawsuit in Maryland

Free Case Review

Start Your Free Review

Answer 2-3 quick questions to review your potential case.

Written By
People's Justice Legal Research Team

Statute of Limitations

Maryland: 3 years from discovery (Md. Code, Cts. & Jud. Proc. § 5-101)

3 years from BIA-ALCL diagnosis or discovery of BIOCELL connection

Filing Venue

Where to File in Maryland

Maryland has a 3-year personal injury statute under Md. Code, Cts. & Jud. Proc. § 5-101, applying from the date of discovery. Maryland plaintiffs file in MDL 2921 in the District of New Jersey. Baltimore and the Maryland suburbs of Washington DC (Bethesda, Chevy Chase, Silver Spring, Rockville) have active plastic surgery markets that placed Allergan BIOCELL products during the 2005–2019 period. Maryland's 3-year window means BIA-ALCL diagnoses from 2023 onward are within the limitations period.

Maryland Data

Exposure in Maryland

Source: FDA MAUDE Database

Source: FDA Safety Communication, July 24, 2019

Back to Allergan Breast Implant Lawsuit Lawsuit Overview